Thus, in myeloid leukemia samples, the frequency of DNMT1 and DNMT3A mutations was high, whereas, in glioblastoma, renal cell carcinoma, and colon carcinoma, the total mutation rate was less than 9% [11]. This evidence concerns the gene DNMT3A and glioblastoma.